Harvard Medical School, Boston, MA, United States.
Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.
Front Immunol. 2024 Apr 30;15:1360219. doi: 10.3389/fimmu.2024.1360219. eCollection 2024.
Regulatory B cells (Bregs) play a pivotal role in suppressing immune responses, yet there is still a lack of cell surface markers that can rigorously identify them. In mouse models for multiple sclerosis (MS), TIM-1 or TIGIT expression on B cells is required for maintaining self-tolerance and regulating autoimmunity to the central nervous system. Here we investigated the activities of human memory B cells that differentially express TIM-1 and TIGIT to determine their potential regulatory function in healthy donors and patients with relapsing-remitting (RR) MS.
FACS-sorted TIM-1+/-TIGIT+/- memory B (memB) cells co-cultured with allogenic CD4+ T cells were analyzed for proliferation and induction of inflammatory markers using flow cytometry and cytokine quantification, to determine Th1/Th17 cell differentiation. Transcriptional differences were assessed by SMARTSeq2 RNA sequencing analysis.
TIM-1-TIGIT- double negative (DN) memB cells strongly induce T cell proliferation and pro-inflammatory cytokine expression. The TIM-1+ memB cells enabled low levels of CD4+ T cell activation and gave rise to T cells that co-express IL-10 with IFNγ and IL-17A or FoxP3. T cells cultured with the TIM-1+TIGIT+ double positive (DP) memB cells exhibited reduced proliferation and IFNγ, IL-17A, TNFα, and GM-CSF expression, and exhibited strong regulation in Breg suppression assays. The functional activity suggests the DP memB cells are a bonafide Breg population. However, MS DP memB cells were less inhibitory than HC DP memB cells. A retrospective longitudinal study of anti-CD20 treated patients found that post-treatment DP memB cell frequency and absolute number were associated with response to therapy. Transcriptomic analyses indicated that the dysfunctional MS-derived DP memB/Breg population exhibited increased expression of genes associated with T cell activation and survival (CD80, ZNF10, PIK3CA), and had distinct gene expression compared to the TIGIT+ or TIM-1+ memB cells.
These findings demonstrate that TIM-1/TIGIT expressing memory B cell subsets have distinct functionalities. Co-expression of TIM-1 and TIGIT defines a regulatory memory B cell subset that is functionally impaired in MS.
调节性 B 细胞(Bregs)在抑制免疫反应中起着关键作用,但仍然缺乏能够严格识别它们的细胞表面标志物。在多发性硬化症(MS)的小鼠模型中,B 细胞上 TIM-1 或 TIGIT 的表达对于维持自身耐受性和调节中枢神经系统自身免疫至关重要。在这里,我们研究了差异表达 TIM-1 和 TIGIT 的人类记忆 B 细胞的活性,以确定它们在健康供体和复发缓解型(RR)MS 患者中的潜在调节功能。
通过流式细胞术和细胞因子定量分析,对 FACS 分选的 TIM-1+/-TIGIT+/-记忆 B(memB)细胞与同种异体 CD4+T 细胞共培养,以确定 Th1/Th17 细胞分化。通过 SMARTSeq2 RNA 测序分析评估转录差异。
TIM-1-TIGIT-双阴性(DN)memB 细胞强烈诱导 T 细胞增殖和促炎细胞因子表达。TIM-1+memB 细胞能够使 CD4+T 细胞激活水平降低,并产生共表达 IFNγ 和 IL-17A 或 FoxP3 的 T 细胞。与 TIM-1+TIGIT+双阳性(DP)memB 细胞共培养的 T 细胞增殖和 IFNγ、IL-17A、TNFα 和 GM-CSF 表达减少,并在 Breg 抑制测定中表现出强烈的调节作用。功能活性表明 DP memB 细胞是真正的 Breg 群体。然而,MS DP memB 细胞的抑制作用不如 HC DP memB 细胞强。对接受抗 CD20 治疗的患者进行回顾性纵向研究发现,治疗后 DP memB 细胞频率和绝对数与治疗反应相关。转录组学分析表明,功能失调的 MS 来源的 DP memB/Breg 群体表现出与 T 细胞激活和存活相关的基因表达增加(CD80、ZNF10、PIK3CA),并且与 TIGIT+或 TIM-1+memB 细胞有明显的基因表达差异。
这些发现表明,表达 TIM-1/TIGIT 的记忆 B 细胞亚群具有不同的功能。TIM-1 和 TIGIT 的共表达定义了一个功能失调的调节性记忆 B 细胞亚群,在 MS 中受损。